UAS Laboratories Overview
- Year Founded
-
1979
- Status
-
Acquired/Merged
- Employees
-
230
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
3
UAS Laboratories General Information
Description
Manufacturer of probiotic products intended to provide trusted probiotic based facilities through the creative application of science, quality and talent that promote healthy living, while exceeding stakeholder expectations. The company specializes in semi-finished and raw-material supplies of probiotic-based supplements and private labeling, providing biotechnology focused research on human health to the healthcare industry.
Contact Information
Website
www.uaslabs.comCorporate Office
- 555 North 72nd Avenue
- Wausau, WI 54401
- United States
Corporate Office
- 555 North 72nd Avenue
- Wausau, WI 54401
- United States
UAS Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
UAS Laboratories Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
UAS Laboratories Patents
UAS Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2578081-T5 | Bacterial compositions for prophylaxis and treatment of degenerative diseases | Active | 01-May-2009 | ||
| ES-2578081-T3 | Bacterial compositions for prophylaxis and treatment of degenerative diseases | Active | 01-May-2009 | ||
| JP-2015127338-A | Bacterial compositions for prophylaxis and treatment of degenerative disease | Pending | 01-May-2009 | ||
| EP-3067056-A1 | Bacterial compositions for prophylaxis and treatment of degenerative disease | Inactive | 01-May-2009 | ||
| EP-2419114-A4 | Bacterial compositions for prophylaxis and treatment of degenerative disease | Active | 01-May-2009 | A61K9/1664 |
UAS Laboratories Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
UAS Laboratories Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
UAS Laboratories Investments & Acquisitions (3)
UAS Laboratories’s most recent deal was a Buyout/LBO with Nebraska Cultures. The deal was made on 03-Apr-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nebraska Cultures | 03-Apr-2018 | Buyout/LBO | Drug Discovery | ||
| Micropharma (intellectual property assets) | 02-Dec-2014 | Buyout/LBO | Buildings and Property | ||
| APN Labs | 12-Nov-2010 | Merger/Acquisition | Pharmaceuticals |
UAS Laboratories FAQs
-
When was UAS Laboratories founded?
UAS Laboratories was founded in 1979.
-
Where is UAS Laboratories headquartered?
UAS Laboratories is headquartered in Wausau, WI.
-
What is the size of UAS Laboratories?
UAS Laboratories has 230 total employees.
-
What industry is UAS Laboratories in?
UAS Laboratories’s primary industry is Pharmaceuticals.
-
Is UAS Laboratories a private or public company?
UAS Laboratories is a Private company.
-
What is the current valuation of UAS Laboratories?
The current valuation of UAS Laboratories is .
-
What is UAS Laboratories’s current revenue?
The current revenue for UAS Laboratories is .
-
How much funding has UAS Laboratories raised over time?
UAS Laboratories has raised $25.7M.
-
Who are UAS Laboratories’s investors?
Greyrock Capital Group and Lakeview Equity Partners have invested in UAS Laboratories.
-
When was UAS Laboratories acquired?
UAS Laboratories was acquired on 27-Jul-2020.
-
Who acquired UAS Laboratories?
UAS Laboratories was acquired by Chr. Hansen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
